Timothy W Corson

2010-2023 Indiana University School of Medicine, Indianapolis, IN, United States 
 2024- University of Toronto, Toronto, ON, Canada 
ophthalmology, angiogenesis, chemical biology, cancer
"Timothy Corson"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Muniyandi A, Jensen NR, Devanathan N, et al. (2024) The Potential of Aqueous Humor Sampling in Diagnosis, Prognosis, and Treatment of Retinoblastoma. Investigative Ophthalmology & Visual Science. 65: 18
Chobisa D, Muniyandi A, Sishtla K, et al. (2023) Long-Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy. Small (Weinheim An Der Bergstrasse, Germany). e2306479
Muniyandi A, Hartman GD, Song Y, et al. (2023) . The Journal of Pharmacology and Experimental Therapeutics
Nassief SM, Amer ME, Shawky E, et al. (2023) Antiangiogenic Pterocarpan and Flavonoid Constituents of . Journal of Natural Products
Muniyandi A, Martin M, Sishtla K, et al. (2023) PRMT5 is a therapeutic target in choroidal neovascularization. Scientific Reports. 13: 1747
Mijit M, Liu S, Sishtla K, et al. (2023) Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. International Journal of Molecular Sciences. 24
Park B, Sardar Pasha SPB, Sishtla KL, et al. (2022) Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization. International Journal of Molecular Sciences. 23
Kwon S, Lee S, Hur J, et al. (2022) Synthesis and Structure Revision of Naturally Occurring Homoisoflavane (+)-Dracaeconolide B. Journal of Natural Products
Jensen NR, Lambert-Cheatham N, Hartman GD, et al. (2022) An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images. Methodsx. 9: 101809
Sishtla K, Lambert-Cheatham N, Lee B, et al. (2022) Small-molecule inhibitors of ferrochelatase are antiangiogenic agents. Cell Chemical Biology
See more...